Typhoid vaccine oral - Prokarium
Alternative Names: M01ZH09; MICRO-TY; Salmonella typhi oral vaccine - Emergent BioSolutions; TyphellaLatest Information Update: 14 Nov 2021
Price :
$50 *
At a glance
- Originator Emergent BioSolutions
- Developer Emergent BioSolutions; Prokarium
- Class Bacterial vaccines; Drug conjugates
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Typhoid
Most Recent Events
- 30 Jan 2009 Emergent BioSolutions completes a phase II trial in Typhoid prevention in USA
- 09 Jan 2008 Final immunogenicity and adverse events data from a Phase-II trial in Typhoid prevention released by Emergent BioSolutions
- 11 Oct 2007 Clinical data added to the adverse events and Bacterial Infections immunogenicity sections